{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T19:47:31Z","timestamp":1791402451287,"version":"4.3.3"},"reference-count":84,"publisher":"Oxford University Press (OUP)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1093\/humrep\/dex027","type":"journal-article","created":{"date-parts":[[2017,1,30]],"date-time":"2017-01-30T13:27:24Z","timestamp":1485782844000},"page":"1033-1045","source":"Crossref","is-referenced-by-count":133,"title":["The safety and efficacy of controlled ovarian hyperstimulation for fertility preservation in women with early breast cancer: a systematic review"],"prefix":"10.1093","volume":"32","author":[{"given":"Rachael J.","family":"Rodgers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey D.","family":"Reid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliette","family":"Koch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Deans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William L.","family":"Ledger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Friedlander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert B.","family":"Gilchrist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsty A.","family":"Walters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason A.","family":"Abbott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,2,27]]},"reference":[{"key":"key\n\t\t\t\t20170417032706_dex027C1","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1093\/oxfordjournals.humrep.a137276","article-title":"Severe ovarian hyperstimulation syndrome in assisted reproductive technology: definition of high risk groups","volume":"6","year":"1991","journal-title":"Hum Reprod"},{"key":"key\n\t\t\t\t20170417032706_dex027C2","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1210\/jc.2007-0247","article-title":"Relative potencies of anastrozole and letrozole to suppress estradiol in breast cancer patients undergoing ovarian stimulation before in vitro fertilization","volume":"92","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t20170417032706_dex027C3","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1093\/jnci\/djs246","article-title":"Preserving fertility in cancer patients","volume":"104","year":"2012","journal-title":"J Natl Cancer Inst"},{"key":"key\n\t\t\t\t20170417032706_dex027C4","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1093\/humrep\/dei475","article-title":"Serum inhibin A, VEGF and TNFalpha levels after triggering oocyte maturation with GnRH agonist compared with HCG in women with polycystic ovaries undergoing IVF treatment: a prospective randomized trial","volume":"21","year":"2006","journal-title":"Hum Reprod"},{"key":"key\n\t\t\t\t20170417032706_dex027C5","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.breast.2004.08.007","article-title":"Tamoxifen and pregnancy","volume":"13","year":"2004","journal-title":"Breast"},{"key":"key\n\t\t\t\t20170417032706_dex027C6","first-page":"753","article-title":"High yield of oocytes without an increase in circulating estradiol levels in breast cancer patients treated with follicle-stimulating hormone and aromatase inhibitor in standard gonadotropin-releasing hormone analogue protocols","volume":"13","year":"2011","journal-title":"IMAJ"},{"key":"key\n\t\t\t\t20170417032706_dex027C7","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jri.2014.06.003","article-title":"Serum but not follicular fluid cytokine levels are increased in stimulated versus natural cycle IVF: a multiplexed assay study","volume":"106","year":"2014","journal-title":"J Reprod Immunol"},{"key":"key\n\t\t\t\t20170417032706_dex027C8","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.ijgo.2008.10.015","article-title":"Effect of estradiol on oocyte development","volume":"104","year":"2009","journal-title":"Int J Gynaecol Obstet"},{"key":"key\n\t\t\t\t20170417032706_dex027C9","doi-asserted-by":"crossref","first-page":"S95","DOI":"10.1016\/j.fertnstert.2005.07.230","article-title":"The outcome of 150 babies following the treatment with letrozole or letrozole and gonadotropins","volume":"84","year":"2005","journal-title":"Fertil Steril"},{"key":"key\n\t\t\t\t20170417032706_dex027C10","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1634\/theoncologist.2011-0121","article-title":"Use of tamoxifen before and during pregnancy","volume":"16","year":"2011","journal-title":"Oncologist"},{"key":"key\n\t\t\t\t20170417032706_dex027C11","doi-asserted-by":"crossref","first-page":"e0145442","DOI":"10.1371\/journal.pone.0145442","article-title":"Neoadjuvant bevacizumab plus chemotherapy versus chemotherapy alone to treat non-metastatic breast cancer: a meta-analysis of randomised controlled trials","volume":"10","year":"2015","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20170417032706_dex027C12","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.rbmo.2012.02.020","article-title":"The effects of letrozole on ovarian stimulation for fertility preservation in cancer-affected women","volume":"24","year":"2012","journal-title":"Reprod Biomed Online"},{"key":"key\n\t\t\t\t20170417032706_dex027C13","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s12943-015-0291-7","article-title":"The role of the insulin-like growth factor-1 system in breast cancer","volume":"14","year":"2015","journal-title":"Mol Cancer"},{"key":"key\n\t\t\t\t20170417032706_dex027C14","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1038\/modpathol.2011.54","article-title":"Androgen receptor expression in breast cancer in relation to molecular phenotype: results from the nurses\u2019 health study","volume":"24","year":"2011","journal-title":"Mod Pathol"},{"key":"key\n\t\t\t\t20170417032706_dex027C15","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/S0046-8177(87)80381-7","article-title":"Teratogenic effects of clomiphene, tamoxifen and diethylstilbestrol on the developing human female genital tract","volume":"18","year":"1987","journal-title":"Hum Pathol"},{"key":"key\n\t\t\t\t20170417032706_dex027C16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1023\/A:1022133219353","article-title":"Estradiol promotes growth and angiogenesis in polyoma middle T transgenic mouse mammary tumor explants","volume":"78","year":"2003","journal-title":"Breast Cancer Res Treat"},{"key":"key\n\t\t\t\t20170417032706_dex027C17","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/BF01807163","article-title":"Time distribution of the recurrence risk for breast cancer patients undergoing mastectomy: further support about the concept of tumor dormancy","volume":"41","year":"1996","journal-title":"Breast Cancer Res Treat"},{"key":"key\n\t\t\t\t20170417032706_dex027C18","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1200\/JCO.2007.13.9279","article-title":"Letrozole suppresses plasma estradiol and estrone sulphate more completely than anastrozole in postmenopausal women with breast cancer","volume":"26","year":"2008","journal-title":"J Clin Oncol"},{"key":"key\n\t\t\t\t20170417032706_dex027C19","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.fertnstert.2012.01.093","article-title":"Ovarian response to controlled ovarian hyperstimulation in cancer patients is diminished even before oncological treatment","volume":"97","year":"2012","journal-title":"Fertil Steril"},{"key":"key\n\t\t\t\t20170417032706_dex027C20","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/S0140-6736(15)61074-1","article-title":"Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials","volume":"386","author":"Early Breast Cancer Trialist's Collaborative Group","year":"2015","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20170417032706_dex027C21","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/S0140-6736(97)11423-4","article-title":"Tamoxifen for early breast cancer: an overview of the randomised trials","volume":"351","author":"Early Breast Cancer Trialists\u2019 Collaborative Group","year":"1998","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20170417032706_dex027C22","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.fertnstert.2007.02.002","article-title":"The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: a prospective randomized controlled study","volume":"89","year":"2008","journal-title":"Fertil Steril"},{"key":"key\n\t\t\t\t20170417032706_dex027C23","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1093\/oxfordjournals.humrep.a135991","article-title":"In-vitro fertilization in completely natural cycles","volume":"10","year":"1995","journal-title":"Hum Reprod"},{"key":"key\n\t\t\t\t20170417032706_dex027C24","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1210\/mend.14.10.0532","article-title":"Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF","volume":"14","year":"2000","journal-title":"Mol Endocrinol"},{"key":"key\n\t\t\t\t20170417032706_dex027C25","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s10911-015-9340-5","article-title":"Steroid hormones, steroid receptors and breast cancer stem cells","volume":"20","year":"2015","journal-title":"J Mammary Gland Biol Neoplasia"},{"key":"key\n\t\t\t\t20170417032706_dex027C26","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/S1701-2163(16)32551-8","article-title":"Fetal safety of letrozole and clomiphene citrate for ovulation induction","volume":"29","year":"2007","journal-title":"J Obstet Gynaecol Can"},{"key":"key\n\t\t\t\t20170417032706_dex027C27","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s10549-011-1611-2","article-title":"Androgens and musculoskeletal symptoms among breast cancer patients on aromatase inhibitor therapy","volume":"130","year":"2011","journal-title":"Breast Cancer Res Treat"},{"key":"key\n\t\t\t\t20170417032706_dex027C28","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/978-3-319-16366-6_2","article-title":"Special issues in younger women with breast cancer","volume":"862","year":"2015","journal-title":"Adv Exp Med Biol"},{"key":"key\n\t\t\t\t20170417032706_dex027C29","first-page":"1230","article-title":"Influence of neoadjuvant anastrozole (arimidex) on intratumoral estrogen levels and proliferation markers in patients with locally advanced breast cancer","volume":"7","year":"2001","journal-title":"Clin Cancer Res"},{"key":"key\n\t\t\t\t20170417032706_dex027C30","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1200\/JCO.2002.20.3.751","article-title":"Influence of letrozole and anastrozole on total body aromatization and plasma estrogen levels in postmenopausal breast cancer patients evaluated in a randomized cross-over study","volume":"20","year":"2002","journal-title":"J Clin Oncol"},{"key":"key\n\t\t\t\t20170417032706_dex027C31","doi-asserted-by":"crossref","first-page":"6330","DOI":"10.1158\/1078-0432.CCR-07-5221","article-title":"Letrozole is superior to anastrozole in suppressing breast cancer tissue and plasma estrogen levels","volume":"14","year":"2008","journal-title":"Clin Cancer Res"},{"key":"key\n\t\t\t\t20170417032706_dex027C32","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/humupd\/dmi045","article-title":"GnRH agonist for triggering final oocyte maturation in the GnRH antagonist ovarian hyperstimulation protocol: a systematic review and meta-analysis","volume":"12","year":"2006","journal-title":"Hum Reprod Update"},{"key":"key\n\t\t\t\t20170417032706_dex027C33","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1093\/humrep\/dem006","article-title":"Elective cryopreservation of all pronuclear oocytes after GnRH agonist triggering of final oocyte maturation in patients at risk of developing OHSS: a prospective, observational proof-of-concept study","volume":"22","year":"2007","journal-title":"Hum Reprod"},{"key":"key\n\t\t\t\t20170417032706_dex027C34","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1200\/JCO.1999.17.5.1474","article-title":"Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer","volume":"17","year":"1999","journal-title":"J Clin Oncol"},{"key":"key\n\t\t\t\t20170417032706_dex027C35","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ejogrb.2014.02.040","article-title":"Serum estradiol level change after human chorionic gonadotropin administration had no correlation with live birth rate in IVF cycles","volume":"178","year":"2014","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"key\n\t\t\t\t20170417032706_dex027C36","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1093\/humrep\/deh765","article-title":"GnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF\/ICSI cycles: a prospective randomized study","volume":"20","year":"2005","journal-title":"Hum Reprod"},{"key":"key\n\t\t\t\t20170417032706_dex027C37","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1093\/humupd\/dmr008","article-title":"GnRH agonist for triggering of final oocyte maturation: time for a change of practice","volume":"17","author":"Copenhagen GnRH Agonist Triggering Workshop Group","year":"2011","journal-title":"Hum Reprod Update"},{"key":"key\n\t\t\t\t20170417032706_dex027C38","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1210\/jc.2015-3878","article-title":"Long-term safety of letrozole and gonadotropin stimulation for fertility preservation in women with breast cancer.pdf","volume":"101","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t20170417032706_dex027C39","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1093\/humrep\/dei150","article-title":"A lower ongoing pregnancy rate can be expected when GnRH agonist is used for triggering final oocyte maturation instead of HCG in patients undergoing IVF with GnRH antagonists","volume":"20","year":"2005","journal-title":"Hum Reprod"},{"key":"key\n\t\t\t\t20170417032706_dex027C40","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.fertnstert.2012.06.015","article-title":"Does higher starting dose of FSH stimulation with letrozole improve fertility preservation outcomes in women with breast cancer","volume":"98","year":"2012","journal-title":"Fertil Steril"},{"key":"key\n\t\t\t\t20170417032706_dex027C41","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1056\/NEJMoa1313517","article-title":"Letrozole versus clomiphene for infertility in the polycystic ovary syndrome","volume":"371","year":"2014","journal-title":"N Eng J Med"},{"key":"key\n\t\t\t\t20170417032706_dex027C42","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1055\/s-2001-17402","article-title":"Peripheral levels of vascular endothelial growth factor (VEGF) are higher in gonadotropin stimulated as compared to natural ovarian cycles","volume":"109","year":"2001","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"key\n\t\t\t\t20170417032706_dex027C43","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1023\/A:1022904624054","article-title":"Estrogen-induced Ets-1 promotes capillary formation in an in vitro tumour angiogenesis model","volume":"78","year":"2003","journal-title":"Breast Cancer Res Treat"},{"key":"key\n\t\t\t\t20170417032706_dex027C44","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1097\/IGC.0000000000000242","article-title":"Safety of pregnancy after surgical treatment for breast cancer: a meta-analysis","volume":"24","year":"2014","journal-title":"Int J Gynecol Cancer"},{"key":"key\n\t\t\t\t20170417032706_dex027C45","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.fertnstert.2014.05.017","article-title":"Tamoxifen co-administration during controlled ovarian hyperstimulation for in vitro fertilization in breast cancer patients increases the safety of fertility-preservation treatment strategies","volume":"102","year":"2014","journal-title":"Fertil Steril"},{"key":"key\n\t\t\t\t20170417032706_dex027C46","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.rbmo.2009.06.001","article-title":"GnRH agonist versus recombinant HCG in an oocyte donation programme: a randomized, prospective, controlled assessor-blind study","volume":"19","year":"2009","journal-title":"Reprod Biomed Online"},{"key":"key\n\t\t\t\t20170417032706_dex027C47","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.fertnstert.2006.02.086","article-title":"Estradiol production during controlled ovarian hyperstimulation correlates with treatment outcome in women undergoing in vitro fertilization-embryo transfer","volume":"86","year":"2006","journal-title":"Fertil Steril"},{"key":"key\n\t\t\t\t20170417032706_dex027C48","doi-asserted-by":"crossref","first-page":"R114","DOI":"10.1186\/bcr3581","article-title":"GPR30 as an initiator of tamoxifen resistance in hormone-dependent breast cancer","volume":"15","year":"2013","journal-title":"Breast Cancer Res"},{"key":"key\n\t\t\t\t20170417032706_dex027C49","doi-asserted-by":"crossref","first-page":"b2535","DOI":"10.1136\/bmj.b2535","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"339","year":"2009","journal-title":"BMJ"},{"key":"key\n\t\t\t\t20170417032706_dex027C50","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1007\/s00404-011-2090-8","article-title":"The effects of peak and mid-luteal estradiol levels on in vitro fertilization outcome","volume":"285","year":"2012","journal-title":"Arch Gynecol Obstet"},{"key":"key\n\t\t\t\t20170417032706_dex027C51","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1093\/oxfordjournals.humrep.a136044","article-title":"Predictive value of serum oestradiol concentrations and oocyte number in severe ovarian hyperstimulation syndrome","volume":"10","year":"1995","journal-title":"Hum Reprod"},{"key":"key\n\t\t\t\t20170417032706_dex027C52","author":"National Institute of Cancer"},{"key":"key\n\t\t\t\t20170417032706_dex027C53","doi-asserted-by":"crossref","first-page":"5589","DOI":"10.1210\/endo.137.12.8940388","article-title":"Estrogen regulates vascular endothelial growth\/permeability factor expression in 7,12-dimethylbenz(a)anthracene-induced rat mammary tumours","volume":"137","year":"1996","journal-title":"Endocrinology"},{"key":"key\n\t\t\t\t20170417032706_dex027C54","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1093\/humrep\/deg045","article-title":"Fertility preservation in breast cancer patients: IVF and embryo cryopreservation after ovarian stimulation with tamoxifen","volume":"18","year":"2003","journal-title":"Hum Reprod"},{"key":"key\n\t\t\t\t20170417032706_dex027C55","doi-asserted-by":"crossref","first-page":"4347","DOI":"10.1200\/JCO.2005.05.037","article-title":"Fertility preservation in breast cancer patients: a prospective controlled comparison of ovarian stimulation with tamoxifen and letrozole for embryo cryopreservation","volume":"23","year":"2005","journal-title":"J Clin Oncol"},{"key":"key\n\t\t\t\t20170417032706_dex027C56","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.rbmo.2010.01.012","article-title":"In vitro maturation improves oocyte or embryo cryopreservation outcome in breast cancer patients undergoing ovarian stimulation for fertility preservation","volume":"20","year":"2010","journal-title":"Reprod Biomed Online"},{"key":"key\n\t\t\t\t20170417032706_dex027C57","doi-asserted-by":"crossref","first-page":"3885","DOI":"10.1210\/jc.2006-0962","article-title":"Letrozole reduces estrogen and gonadotropin exposure in women with breast cancer undergoing ovarian stimulation before chemotherapy","volume":"91","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t20170417032706_dex027C58","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.rbmo.2010.03.004","article-title":"GnRH agonist trigger for women with breast cancer undergoing fertility preservation by aromatase inhibitor\/FSH stimulation","volume":"20","year":"2010","journal-title":"Reprod Biomed Online"},{"key":"key\n\t\t\t\t20170417032706_dex027C59","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/emboj.2008.304","article-title":"Estrogenic GPR30 signalling induces proliferation and migration of breast cancer cells through CTGF","volume":"28","year":"2009","journal-title":"EMBO J"},{"key":"key\n\t\t\t\t20170417032706_dex027C60","doi-asserted-by":"crossref","first-page":"4174","DOI":"10.1200\/JCO.2004.01.159","article-title":"Web-based survey of fertility issues in young women with breast cancer","volume":"22","year":"2004","journal-title":"J Clin Oncol"},{"key":"key\n\t\t\t\t20170417032706_dex027C61","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1200\/JCO.2008.16.1976","article-title":"Fertility preservation: a vital survivorship issue for young women with breast cancer","volume":"26","year":"2008","journal-title":"J Clin Oncol"},{"key":"key\n\t\t\t\t20170417032706_dex027C62","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s10815-015-0434-1","article-title":"Impact of elevated peak serum estradiol levels during controlled ovarian hyperstimulation on the birth weight of term singletons from fresh IVF-ET cycles","volume":"32","year":"2015","journal-title":"J Assist Reprod Genet"},{"key":"key\n\t\t\t\t20170417032706_dex027C63","doi-asserted-by":"crossref","first-page":"6131","DOI":"10.1158\/0008-5472.CAN-09-0452","article-title":"Androgen receptor inhibits estrogen receptor-a activity and is prognostic in breast cancer","volume":"69","year":"2009","journal-title":"Cancer Res"},{"key":"key\n\t\t\t\t20170417032706_dex027C64","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1146\/annurev.physiol.70.113006.100518","article-title":"Estrogen signalling through the transmembrane G protein-coupled receptor GPR30","volume":"70","year":"2008","journal-title":"Ann Rev Physiol"},{"key":"key\n\t\t\t\t20170417032706_dex027C65","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.fertnstert.2008.10.007","article-title":"Ovarian stimulation for fertility preservation in patients with cancer","volume":"93","year":"2010","journal-title":"Fertil Steril"},{"key":"key\n\t\t\t\t20170417032706_dex027C66","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1186\/bcr1330","article-title":"What does an orphan G-protein-coupled receptor have to do with estrogen","volume":"7","year":"2005","journal-title":"Breast Cancer Res"},{"key":"key\n\t\t\t\t20170417032706_dex027C67","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.3747\/co.22.2338","article-title":"Outcome of patients with pregnancy during or after breast cancer: a review of the recent literature","volume":"22","year":"2015","journal-title":"Curr Oncol"},{"key":"key\n\t\t\t\t20170417032706_dex027C68","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1007\/s10815-014-0248-6","article-title":"Triggering final oocyte maturation with gonadotropin-releasing hormone agonist (GnRHa) versus human chorionic gonadotropin (hCG) in breast cancer patients undergoing fertility preservation: an extended experience","volume":"31","year":"2014","journal-title":"J Assist Reprod Genet"},{"key":"key\n\t\t\t\t20170417032706_dex027C69","doi-asserted-by":"crossref","first-page":"993","DOI":"10.3109\/09513590.2013.819083","article-title":"Is letrozole needed for controlled ovarian stimulation in patients with estrogen receptor-positive breast cancer","volume":"29","year":"2013","journal-title":"Gynecol Endocrinol"},{"key":"key\n\t\t\t\t20170417032706_dex027C70","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1200\/JCO.2013.52.8877","article-title":"Prospective study of fertility concerns and preservation strategies in young women with breast cancer","volume":"32","year":"2014","journal-title":"J Clin Oncol"},{"key":"key\n\t\t\t\t20170417032706_dex027C71","doi-asserted-by":"crossref","first-page":"e108219","DOI":"10.1371\/journal.pone.0108219","article-title":"Congenital malformations among babies born following Letrozole or Clomiphene for infertility treatment","volume":"9","year":"2014","journal-title":"PLoS"},{"key":"key\n\t\t\t\t20170417032706_dex027C72","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/OGX.0b013e31816400d7","article-title":"Selective estrogen receptor modulators: an update on recent clinical findings","volume":"63","year":"2008","journal-title":"Obstet Gynecol Surv"},{"key":"key\n\t\t\t\t20170417032706_dex027C73","first-page":"93s","article-title":"Tamoxifen for patients with estrogen receptor-negative breast cancer","volume":"19","year":"2001","journal-title":"J Clin Oncol"},{"key":"key\n\t\t\t\t20170417032706_dex027C74","first-page":"125","article-title":"No increased risk of major congenital anomalies or adverse pregnancy or neonatal outcomes following letrozole use in assisted reproductive technology","volume":"32","year":"2017","journal-title":"Hum Reprod"},{"key":"key\n\t\t\t\t20170417032706_dex027C75","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1007\/s10637-015-0249-z","article-title":"The effect of paclitaxel and nab-paclitaxel in combination with anti-angiogenic therapy in breast cancer cell lines","volume":"33","year":"2015","journal-title":"Invest New Drugs"},{"key":"key\n\t\t\t\t20170417032706_dex027C76","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1093\/ije\/dyg094","article-title":"Maternal serum oestrogen and androgen concentrations in preeclamptic and uncomplicated pregnancies","volume":"32","year":"2003","journal-title":"Int J Epidemiol"},{"key":"key\n\t\t\t\t20170417032706_dex027C77","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1016\/j.fertnstert.2006.03.014","article-title":"Congenital malformations among 911 newborns conceived after infertility treatment with letrozole or clomiphene citrate","volume":"85","year":"2006","journal-title":"Fertil Steril"},{"key":"key\n\t\t\t\t20170417032706_dex027C78","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1016\/j.fertnstert.2013.08.030","article-title":"Safety and feasibility of performing two consecutive ovarian stimulation cycles with the use of letrozole-gonadotropin protocol for fertility preservation in breast cancer patients","volume":"100","year":"2013","journal-title":"Fertil Steril"},{"key":"key\n\t\t\t\t20170417032706_dex027C79","first-page":"786","article-title":"Safety of pregnancy after primary breast carcinoma in young women: a meta-analysis to overcome bias of healthy mother effect studies","volume":"65","year":"2011","journal-title":"Obstet Gynecol Surv"},{"key":"key\n\t\t\t\t20170417032706_dex027C80","author":"WHO","year":"2012"},{"key":"key\n\t\t\t\t20170417032706_dex027C81","author":"WHO","year":"2012"},{"key":"key\n\t\t\t\t20170417032706_dex027C82","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S1028-4559(08)60108-4","article-title":"High serum estradiol levels are not detrimental to in vitro fertilization outcome","volume":"46","year":"2007","journal-title":"Taiwanese J Obstet Gynecol"},{"key":"key\n\t\t\t\t20170417032706_dex027C83","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.3892\/or.2015.4166","article-title":"12-deoxyphorbol 13-palmitate inhibits the expression of VEGF and HIF-1a in MCF-7 cells by blocking the PI3K\/Akt\/mTOR signalling pathway","volume":"34","year":"2015","journal-title":"Oncol Rep"},{"key":"key\n\t\t\t\t20170417032706_dex027C84","first-page":"CD008046","article-title":"Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist-assisted reproductive technology","volume":"10","year":"2014","journal-title":"Cochrane Database Syst Rev"}],"container-title":["Human Reproduction"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/humrep\/article-pdf\/32\/5\/1033\/13620597\/dex027.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,23]],"date-time":"2022-07-23T01:09:34Z","timestamp":1658538574000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/humrep\/article-lookup\/doi\/10.1093\/humrep\/dex027"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,27]]},"references-count":84,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2017,2,27]]},"published-print":{"date-parts":[[2017,5]]}},"URL":"https:\/\/doi.org\/10.1093\/humrep\/dex027","relation":{},"ISSN":["0268-1161","1460-2350"],"issn-type":[{"value":"0268-1161","type":"print"},{"value":"1460-2350","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,27]]}}}